TreeWAS – Variant ID: rs1155865

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
L40.9 Psoriasis, unspecified	0.000	0.945	0.055
L40 Psoriasis	0.000	0.953	0.047
L40.5 Arthropathic psoriasis	0.000	0.957	0.043
L40.3 Pustulosis palmaris et plantaris	0.000	0.962	0.038
L40.0 Psoriasis vulgaris	0.000	0.962	0.038
L40.4 Guttate psoriasis	0.000	0.964	0.035
L40.2 Acrodermatitis continua	0.000	0.966	0.034
L40.8 Other psoriasis	0.000	0.967	0.033
L40.1 Generalised pustular psoriasis	0.000	0.968	0.031
D46.9 Myelodysplastic syndrome, unspecified	0.000	0.983	0.017
N28.8 Other specified disorders of kidney and ureter	0.000	0.986	0.014
D46 Myelodysplastic syndromes	0.000	0.987	0.013
D07.1 Vulva	0.000	0.987	0.013
L40-L45 Papulosquamous disorders	0.000	0.988	0.012
N28.0 Ischaemia and infarction of kidney	0.000	0.988	0.012
D46.7 Other myelodysplastic syndromes	0.000	0.988	0.012
N28 Other disorders of kidney and ureter, not elsewhere classified	0.000	0.988	0.012
D46.2 Refractory anaemia with excess of blasts	0.000	0.989	0.011
D46.1 Refractory anaemia with sideroblasts	0.000	0.990	0.010
D46.4 Refractory anaemia, unspecified	0.000	0.990	0.010
N28.9 Disorder of kidney and ureter, unspecified	0.000	0.990	0.010
I46.0 Cardiac arrest with successful resuscitation	0.000	0.990	0.010
D46.6 Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality	0.000	0.990	0.010
D46.3 Refractory anaemia with excess of blasts with transformation	0.000	0.990	0.010
D46.0 Refractory anaemia without sideroblasts, so stated	0.000	0.990	0.010
D46.5 Refractory anaemia with multi-lineage dysplasia	0.000	0.990	0.010
M25.55 Pain in joint (Pelvic region and thigh)	0.009	0.991	0.000
L45 Papulosquamous disorders in diseases classified elsewhere	0.000	0.991	0.009
M45.X9 Ankylosing spondylitis (Site unspecified)	0.000	0.991	0.009
L41 Parapsoriasis	0.000	0.991	0.009
L44 Other papulosquamous disorders	0.000	0.991	0.009
A41.8 Other specified septicaemia	0.000	0.991	0.009
R41.3 Other amnesia	0.000	0.991	0.009
L42 Pityriasis rosea	0.000	0.992	0.008
A41.5 Septicaemia due to other Gram-negative organisms	0.000	0.992	0.008
M10.99 Gout, unspecified (Site unspecified)	0.008	0.992	0.000
G93.8 Other specified disorders of brain	0.008	0.992	0.000
A41 Other septicaemia	0.000	0.992	0.008
L43 Lichen planus	0.000	0.992	0.007
A41.2 Septicaemia due to unspecified staphylococcus	0.000	0.993	0.007
G93.6 Cerebral oedema	0.007	0.993	0.000
G93 Other disorders of brain	0.007	0.993	0.000
N90.8 Other specified noninflammatory disorders of vulva and perineum	0.000	0.993	0.007
A41.1 Septicaemia due to other specified staphylococcus	0.000	0.993	0.007
N25-N29 Other disorders of kidney and ureter	0.000	0.993	0.007
L41.9 Parapsoriasis, unspecified	0.000	0.993	0.006
L41.8 Other parapsoriasis	0.000	0.993	0.006
L41.5 Retiform parapsoriasis	0.000	0.993	0.006
L41.4 Large plaque parapsoriasis	0.000	0.993	0.006
L41.3 Small plaque parapsoriasis	0.000	0.993	0.006
L41.2 Lymphomatoid papulosis	0.000	0.993	0.006
L41.0 Pityriasis lichenoides et varioliformis acuta	0.000	0.993	0.006
G97.1 Other reaction to spinal and lumbar puncture	0.006	0.993	0.000
L44.9 Papulosquamous disorder, unspecified	0.000	0.993	0.006
L44.8 Other specified papulosquamous disorders	0.000	0.993	0.006
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]	0.000	0.993	0.006
L44.3 Lichen ruber moniliformis	0.000	0.993	0.006
L44.2 Lichen striatus	0.000	0.993	0.006
L44.1 Lichen nitidus	0.000	0.993	0.006
G97 Postprocedural disorders of nervous system, not elsewhere classified	0.006	0.994	0.000
L41.1 Pityriasis lichenoides chronica	0.000	0.994	0.006
A41.4 Septicaemia due to anaerobes	0.000	0.994	0.006
G90-G99 Other disorders of the nervous system	0.006	0.994	0.000
L44.0 Pityriasis rubra pilaris	0.000	0.994	0.006
N29 Other disorders of kidney and ureter in diseases classified elsewhere	0.000	0.994	0.006
G93.3 Postviral fatigue syndrome	0.006	0.994	0.000
I83.9 Varicose veins of lower extremities without ulcer or inflammation	0.000	0.994	0.006
G96 Other disorders of central nervous system	0.006	0.994	0.000
L43.3 Subacute (active) lichen planus	0.000	0.994	0.006
L43.2 Lichenoid drug reaction	0.000	0.994	0.006
L43.1 Bullous lichen planus	0.000	0.994	0.006
G90 Disorders of autonomic nervous system	0.006	0.994	0.000
N27 Small kidney of unknown cause	0.000	0.994	0.005
A41.3 Septicaemia due to Haemophilus influenzae	0.000	0.994	0.005
L43.8 Other lichen planus	0.000	0.994	0.005
G93.2 Benign intracranial hypertension	0.005	0.994	0.000
N25 Disorders resulting from impaired renal tubular function	0.000	0.995	0.005
G93.7 Reye's syndrome	0.005	0.995	0.000
G93.0 Cerebral cysts	0.005	0.995	0.000
L43.0 Hypertrophic lichen planus	0.000	0.995	0.005
N29.8 Other disorders of kidney and ureter in other diseases classified elsewhere	0.000	0.995	0.005
G97.8 Other postprocedural disorders of nervous system	0.005	0.995	0.000
G95 Other diseases of spinal cord	0.005	0.995	0.000
G98 Other disorders of nervous system, not elsewhere classified	0.005	0.995	0.000
G93.5 Compression of brain	0.005	0.995	0.000
G90.9 Disorder of autonomic nervous system, unspecified	0.005	0.995	0.000
N90 Other noninflammatory disorders of vulva and perineum	0.000	0.995	0.005
G96.8 Other specified disorders of central nervous system	0.005	0.995	0.000
I74.3 Embolism and thrombosis of arteries of the lower extremities	0.000	0.995	0.005
N99.8 Other postprocedural disorders of genito-urinary system	0.000	0.995	0.005
N99.5 Malfunction of external stoma of urinary tract	0.000	0.995	0.005
M45 Ankylosing spondylitis	0.000	0.995	0.005
N26 Unspecified contracted kidney	0.000	0.995	0.005
T42.4 Benzodiazepines	0.005	0.995	0.000
N99 Postprocedural disorders of genito-urinary system, not elsewhere classified	0.000	0.995	0.005
G90.2 Horner's syndrome	0.005	0.995	0.000
G95.9 Disease of spinal cord, unspecified	0.005	0.995	0.000
I46 Cardiac arrest	0.000	0.995	0.005
G97.9 Postprocedural disorder of nervous system, unspecified	0.005	0.995	0.000
G97.2 Intracranial hypotension following ventricular shunting	0.005	0.995	0.000
J43.9 Emphysema, unspecified	0.000	0.995	0.005
N90.7 Vulvar cyst	0.000	0.995	0.005
G94 Other disorders of brain in diseases classified elsewhere	0.005	0.995	0.000
G96.0 Cerebrospinal fluid leak	0.005	0.995	0.000
L43.9 Lichen planus, unspecified	0.000	0.995	0.005
N27.0 Small kidney, unilateral	0.000	0.995	0.005
G93.4 Encephalopathy, unspecified	0.005	0.995	0.000
G96.9 Disorder of central nervous system, unspecified	0.004	0.995	0.000
N25.8 Other disorders resulting from impaired renal tubular function	0.000	0.995	0.004
D07 Carcinoma in situ of other and unspecified genital organs	0.000	0.995	0.004
N29.0 Late syphilis of kidney	0.000	0.995	0.004
C43.5 Malignant melanoma of trunk	0.005	0.995	0.000
G95.0 Syringomyelia and syringobulbia	0.004	0.995	0.000
K81.1 Chronic cholecystitis	0.005	0.995	0.000
N90.9 Noninflammatory disorder of vulva and perineum, unspecified	0.000	0.995	0.004
G96.1 Disorders of meninges, not elsewhere classified	0.004	0.996	0.000
K46.9 Unspecified abdominal hernia without obstruction or gangrene	0.004	0.996	0.000
A41.9 Septicaemia, unspecified	0.000	0.996	0.004
N29.1 Other disorders of kidney and ureter in infectious and parasitic diseases classified elsewhere	0.000	0.996	0.004
N99.1 Postprocedural urethral stricture	0.000	0.996	0.004
M10.9 Gout, unspecified	0.004	0.996	0.000
M45.X0 Ankylosing spondylitis (Multiple sites in spine)	0.000	0.996	0.004
N27.1 Small kidney, bilateral	0.000	0.996	0.004
N90.3 Dysplasia of vulva, unspecified	0.000	0.996	0.004
N90.1 Moderate vulvar dysplasia	0.000	0.996	0.004
N99.3 Prolapse of vaginal vault after hysterectomy	0.000	0.996	0.004
G95.2 Cord compression, unspecified	0.004	0.996	0.000
G90.4 Autonomic dysreflexia	0.004	0.996	0.000
G90.3 Multisystem degeneration	0.004	0.996	0.000
G90.1 Familial dysautonomia [Riley-Day]	0.004	0.996	0.000
G92 Toxic encephalopathy	0.004	0.996	0.000
G97.0 Cerebrospinal fluid leak from spinal puncture	0.004	0.996	0.000
N25.1 Nephrogenic diabetes insipidus	0.000	0.996	0.004
C43.3 Malignant melanoma of other and unspecified parts of face	0.004	0.996	0.000
M45.X7 Ankylosing spondylitis (Lumbosacral region)	0.000	0.996	0.004
N90.0 Mild vulvar dysplasia	0.000	0.996	0.004
N27.9 Small kidney, unspecified	0.000	0.996	0.004
G90.8 Other disorders of autonomic nervous system	0.004	0.996	0.000
G90.0 Idiopathic peripheral autonomic neuropathy	0.004	0.996	0.000
N90.4 Leukoplakia of vulva	0.000	0.996	0.004
N99.9 Postprocedural disorder of genito-urinary system, unspecified	0.000	0.996	0.004
I46.9 Cardiac arrest, unspecified	0.000	0.996	0.004
G93.1 Anoxic brain damage, not elsewhere classified	0.004	0.996	0.000
N25.9 Disorder resulting from impaired renal tubular function, unspecified	0.000	0.996	0.004
N90.2 Severe vulvar dysplasia, not elsewhere classified	0.000	0.996	0.004
N25.0 Renal osteodystrophy	0.000	0.996	0.004
A41.0 Septicaemia due to Staphylococcus aureus	0.000	0.996	0.004
D07.3 Other and unspecified female genital organs	0.000	0.996	0.004
M10.94 Gout, unspecified (Hand)	0.004	0.996	0.000
M45.X8 Ankylosing spondylitis (Sacral and sacrococcygeal region)	0.000	0.996	0.004
M45.X5 Ankylosing spondylitis (Thoracolumbar region)	0.000	0.996	0.004
M45.X4 Ankylosing spondylitis (Thoracic region)	0.000	0.996	0.004
M45.X3 Ankylosing spondylitis (Cervicothoracic region)	0.000	0.996	0.004
M45.X1 Ankylosing spondylitis (Occipito-atlanto-axial region)	0.000	0.996	0.004
D07.2 Vagina	0.000	0.996	0.004
M10.90 Gout, unspecified (Multiple sites)	0.004	0.996	0.000
N99.2 Postprocedural adhesions of vagina	0.000	0.996	0.004
G95.1 Vascular myelopathies	0.004	0.996	0.000
K57.2 Diverticular disease of large intestine with perforation and abscess	0.004	0.996	0.000
M45.X6 Ankylosing spondylitis (Lumbar region)	0.000	0.996	0.004
N90.6 Hypertrophy of vulva	0.000	0.996	0.004
D59.1 Other autoimmune haemolytic anaemias	0.000	0.996	0.004
M45.X2 Ankylosing spondylitis (Cervical region)	0.000	0.996	0.004
I46.1 Sudden cardiac death, so described	0.000	0.996	0.004
G94.1 Hydrocephalus in neoplastic disease	0.003	0.996	0.000
G94.8 Other specified disorders of brain in diseases classified elsewhere	0.003	0.996	0.000
G94.2 Hydrocephalus in other diseases classified elsewhere	0.003	0.996	0.000
G94.0 Hydrocephalus in infectious and parasitic diseases classified elsewhere	0.003	0.996	0.000
C43 Malignant melanoma of skin	0.004	0.996	0.000
T39.0 Salicylates	0.004	0.996	0.000
M07.39 Other psoriatic arthropathies (Site unspecified)	0.000	0.996	0.004
D07.6 Other and unspecified male genital organs	0.000	0.996	0.003
D07.4 Penis	0.000	0.996	0.003
G93.9 Disorder of brain, unspecified	0.003	0.996	0.000
M10.98 Gout, unspecified (Other)	0.003	0.997	0.000
M10.95 Gout, unspecified (Pelvic region and thigh)	0.003	0.997	0.000
M10.91 Gout, unspecified (Shoulder region)	0.003	0.997	0.000
L98.8 Other specified disorders of skin and subcutaneous tissue	0.000	0.997	0.003
N99.4 Postprocedural pelvic peritoneal adhesions	0.000	0.997	0.003
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.003	0.997	0.000
N99.0 Postprocedural renal failure	0.000	0.997	0.003
M10.97 Gout, unspecified (Ankle and foot)	0.003	0.997	0.000
M48.02 Spinal stenosis (Cervical region)	0.003	0.997	0.000
D07.0 Endometrium	0.000	0.997	0.003
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.003	0.997	0.000
M10.92 Gout, unspecified (Upper arm)	0.003	0.997	0.000
C43.6 Malignant melanoma of upper limb, including shoulder	0.003	0.997	0.000
C43.2 Malignant melanoma of ear and external auricular canal	0.003	0.997	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.003	0.997	0.000
M10.93 Gout, unspecified (Forearm)	0.003	0.997	0.000
O68.9 Labour and delivery complicated by foetal stress, unspecified	0.003	0.997	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.003	0.997	0.000
C43.0 Malignant melanoma of lip	0.003	0.997	0.000
D48.1 Connective and other soft tissue	0.000	0.997	0.003
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.003	0.997	0.000
F25 Schizoaffective disorders	0.000	0.997	0.003
F20.9 Schizophrenia, unspecified	0.000	0.997	0.003
T38.1 Thyroid hormones and substitutes	0.003	0.997	0.000
C43.8 Overlapping malignant melanoma of skin	0.003	0.997	0.000
F20 Schizophrenia	0.000	0.997	0.003
C43.9 Malignant melanoma of skin, unspecified	0.003	0.997	0.000
M48.0 Spinal stenosis	0.003	0.997	0.000
F25.0 Schizoaffective disorder, manic type	0.000	0.997	0.003
T42.0 Hydantoin derivatives	0.003	0.997	0.000
M10.96 Gout, unspecified (Lower leg)	0.003	0.997	0.000
F22 Persistent delusional disorders	0.000	0.997	0.003
T46 Poisoning by agents primarily affecting the cardiovascular system	0.003	0.997	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.003	0.997	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.003	0.997	0.000
T39.1 4-Aminophenol derivatives	0.003	0.997	0.000
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.000	0.997	0.003
C43.7 Malignant melanoma of lower limb, including hip	0.003	0.997	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.003	0.997	0.000
D59 Acquired haemolytic anaemia	0.000	0.997	0.003
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.003	0.997	0.000
T42.3 Barbiturates	0.003	0.997	0.000
T39.4 Antirheumatics, not elsewhere classified	0.003	0.997	0.000
T39.2 Pyrazolone derivatives	0.003	0.997	0.000
M48.00 Spinal stenosis (Multiple sites in spine)	0.003	0.997	0.000
H61.0 Perichondritis of external ear	0.000	0.997	0.003
T38.8 Other and unspecified hormones and their synthetic substitutes	0.003	0.997	0.000
F22.0 Delusional disorder	0.000	0.997	0.003
G95.8 Other specified diseases of spinal cord	0.002	0.997	0.000
D05.1 Intraductal carcinoma in situ	0.000	0.997	0.003
G91 Hydrocephalus	0.002	0.997	0.000
T38.0 Glucocorticoids and synthetic analogues	0.003	0.997	0.000
F20.8 Other schizophrenia	0.000	0.997	0.003
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.003	0.997	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.002	0.997	0.000
T42.2 Succinimides and oxazolidinediones	0.002	0.997	0.000
F22.9 Persistent delusional disorder, unspecified	0.000	0.997	0.003
X49.9 Unspecified place	0.003	0.997	0.000
F25.9 Schizoaffective disorder, unspecified	0.000	0.997	0.003
M48.07 Spinal stenosis (Lumbosacral region)	0.003	0.997	0.000
F29 Unspecified nonorganic psychosis	0.000	0.997	0.003
M48.09 Spinal stenosis (Site unspecified)	0.003	0.997	0.000
D59.9 Acquired haemolytic anaemia, unspecified	0.000	0.997	0.002
F25.1 Schizoaffective disorder, depressive type	0.000	0.997	0.002
T38.9 Other and unspecified hormone antagonists	0.002	0.997	0.000
T38.7 Androgens and anabolic congeners	0.002	0.997	0.000
T38.4 Oral contraceptives	0.002	0.997	0.000
T38.2 Antithyroid drugs	0.002	0.997	0.000
D05.9 Carcinoma in situ of breast, unspecified	0.000	0.997	0.003
N13.1 Hydronephrosis with ureteral stricture, not elsewhere classified	0.000	0.997	0.003
F20.5 Residual schizophrenia	0.000	0.997	0.002
T38.5 Other oestrogens and progestogens	0.002	0.997	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.997	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.002	0.997	0.000
G99 Other disorders of nervous system in diseases classified elsewhere	0.002	0.998	0.000
D59.4 Other nonautoimmune haemolytic anaemias	0.000	0.998	0.002
T45.0 Antiallergic and antiemetic drugs	0.002	0.998	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.002	0.998	0.000
F25.2 Schizoaffective disorder, mixed type	0.000	0.998	0.002
F25.8 Other schizoaffective disorders	0.000	0.998	0.002
C43.1 Malignant melanoma of eyelid, including canthus	0.002	0.998	0.000
G91.8 Other hydrocephalus	0.002	0.998	0.000
K81.9 Cholecystitis, unspecified	0.002	0.998	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.998	0.000
M48.05 Spinal stenosis (Thoracolumbar region)	0.002	0.998	0.000
N90.5 Atrophy of vulva	0.000	0.998	0.002
T42.1 Iminostilbenes	0.002	0.998	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.002	0.998	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.002	0.998	0.000
M48.03 Spinal stenosis (Cervicothoracic region)	0.002	0.998	0.000
M48.01 Spinal stenosis (Occipito-atlanto-axial region)	0.002	0.998	0.000
F20.6 Simple schizophrenia	0.000	0.998	0.002
F20.4 Postschizophrenic depression	0.000	0.998	0.002
F20.3 Undifferentiated schizophrenia	0.000	0.998	0.002
F20.1 Hebephrenic schizophrenia	0.000	0.998	0.002
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.998	0.000
F22.8 Other persistent delusional disorders	0.000	0.998	0.002
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.002	0.998	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
M07.3 Other psoriatic arthropathies	0.000	0.998	0.002
T46.8 Antivaricose drugs, including sclerosing agents	0.002	0.998	0.000
T46.7 Peripheral vasodilators	0.002	0.998	0.000
F23 Acute and transient psychotic disorders	0.000	0.998	0.002
F28 Other nonorganic psychotic disorders	0.000	0.998	0.002
F24 Induced delusional disorder	0.000	0.998	0.002
F21 Schizotypal disorder	0.000	0.998	0.002
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.002	0.998	0.000
D59.8 Other acquired haemolytic anaemias	0.000	0.998	0.002
D59.6 Haemoglobinuria due to haemolysis from other external causes	0.000	0.998	0.002
D59.5 Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]	0.000	0.998	0.002
D59.3 Haemolytic-uraemic syndrome	0.000	0.998	0.002
D59.2 Drug-induced nonautoimmune haemolytic anaemia	0.000	0.998	0.002
T46.3 Coronary vasodilators, not elsewhere classified	0.002	0.998	0.000
D59.0 Drug-induced autoimmune haemolytic anaemia	0.000	0.998	0.002
M48.04 Spinal stenosis (Thoracic region)	0.002	0.998	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.002	0.998	0.000
D33.3 Cranial nerves	0.002	0.998	0.000
M18.0 Primary arthrosis of first carpometacarpal joints, bilateral	0.002	0.998	0.000
F20.2 Catatonic schizophrenia	0.000	0.998	0.002
K46 Unspecified abdominal hernia	0.002	0.998	0.000
M23.81 Other internal derangements of knee (Anterior cruciate ligament or Anterior horn of medial meniscus)	0.000	0.998	0.002
N28.1 Cyst of kidney, acquired	0.000	0.998	0.002
M48.08 Spinal stenosis (Sacral and sacrococcygeal region)	0.002	0.998	0.000
T46.1 Calcium-channel blockers	0.002	0.998	0.000
D05 Carcinoma in situ of breast	0.000	0.998	0.002
J06.9 Acute upper respiratory infection, unspecified	0.000	0.998	0.002
T46.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.998	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.002	0.998	0.000
N99-N99 Other disorders of the genitourinary system	0.000	0.998	0.002
M84.17 Nonunion of fracture [pseudarthrosis] (Ankle and foot)	0.000	0.998	0.002
M07.36 Other psoriatic arthropathies (Lower leg)	0.000	0.998	0.002
M07.34 Other psoriatic arthropathies (Hand)	0.000	0.998	0.002
C43.4 Malignant melanoma of scalp and neck	0.002	0.998	0.000
G37.9 Demyelinating disease of central nervous system, unspecified	0.002	0.998	0.000
F20.0 Paranoid schizophrenia	0.000	0.998	0.002
M18.1 Other primary arthrosis of first carpometacarpal joint	0.002	0.998	0.000
M48 Other spondylopathies	0.002	0.998	0.000
M48.55 Collapsed vertebra, not elsewhere classified (Thoracolumbar region)	0.002	0.998	0.000
G99.8 Other specified disorders of nervous system in diseases classified elsewhere	0.002	0.998	0.000
G99.1 Other disorders of autonomic nervous system in other diseases classified elsewhere	0.002	0.998	0.000
M48.5 Collapsed vertebra, not elsewhere classified	0.002	0.998	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
T48.4 Expectorants	0.002	0.998	0.000
T48.3 Antitussives	0.002	0.998	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
T48.0 Oxytocic drugs	0.002	0.998	0.000
F23.8 Other acute and transient psychotic disorders	0.000	0.998	0.002
T47.6 Antidiarrhoeal drugs	0.002	0.998	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.002	0.998	0.000
T36 Poisoning by systemic antibiotics	0.002	0.998	0.000
G91.3 Posttraumatic hydrocephalus, unspecified	0.002	0.998	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.000	0.998	0.002
T46.4 Angiotensin-converting-enzyme inhibitors	0.002	0.998	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.998	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.002	0.998	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
F23.1 Acute polymorphic psychotic disorder with symptoms of schizophrenia	0.000	0.998	0.002
K46.0 Unspecified abdominal hernia with obstruction, without gangrene	0.002	0.998	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.002	0.998	0.000
Z45.2 Adjustment and management of vascular access device	0.000	0.998	0.002
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.002	0.998	0.000
T50.1 Loop [high-ceiling] diuretics	0.002	0.998	0.000
Z41.1 Other plastic surgery for unacceptable cosmetic appearance	0.000	0.998	0.002
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
T47.7 Emetics	0.002	0.998	0.000
T47.5 Digestants	0.002	0.998	0.000
T47.3 Saline and osmotic laxatives	0.002	0.998	0.000
T47.0 Histamine H(2)-receptor antagonists	0.002	0.998	0.000
T49.9 Topical agent, unspecified	0.002	0.998	0.000
T49.8 Other topical agents	0.002	0.998	0.000
T49.7 Dental drugs, topically applied	0.002	0.998	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.002	0.998	0.000
T49.5 Ophthalmological drugs and preparations	0.002	0.998	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
T49.3 Emollients, demulcents and protectants	0.002	0.998	0.000
T49.2 Local astringents and local detergents	0.002	0.998	0.000
T49.1 Antipruritics	0.002	0.998	0.000
T47.4 Other laxatives	0.002	0.998	0.000
T48.5 Anti-common-cold drugs	0.002	0.998	0.000
M07.33 Other psoriatic arthropathies (Forearm)	0.000	0.998	0.002
M07.32 Other psoriatic arthropathies (Upper arm)	0.000	0.998	0.002
M07.31 Other psoriatic arthropathies (Shoulder region)	0.000	0.998	0.002
M07.37 Other psoriatic arthropathies (Ankle and foot)	0.000	0.998	0.002
M48.56 Collapsed vertebra, not elsewhere classified (Lumbar region)	0.002	0.998	0.000
F23.2 Acute schizophrenia-like psychotic disorder	0.000	0.998	0.002
T45.9 Primarily systemic and haematological agent, unspecified	0.002	0.998	0.000
T45.8 Other primarily systemic and haematological agents	0.002	0.998	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
T45.6 Fibrinolysis-affecting drugs	0.002	0.998	0.000
T45.3 Enzymes, not elsewhere classified	0.002	0.998	0.000
T50.7 Analeptics and opioid receptor antagonists	0.002	0.998	0.000
T50.5 Appetite depressants	0.002	0.998	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
T50.0 Mineralocorticoids and their antagonists	0.002	0.998	0.000
D05.7 Other carcinoma in situ of breast	0.000	0.998	0.002
D07.5 Prostate	0.001	0.998	0.001
F23.0 Acute polymorphic psychotic disorder without symptoms of schizophrenia	0.000	0.998	0.002
G91.0 Communicating hydrocephalus	0.002	0.998	0.000
T41.5 Therapeutic gases	0.002	0.998	0.000
T41.4 Anaesthetic, unspecified	0.002	0.998	0.000
T41.3 Local anaesthetics	0.002	0.998	0.000
T41.1 Intravenous anaesthetics	0.002	0.998	0.000
T41.0 Inhaled anaesthetics	0.002	0.998	0.000
T47.2 Stimulant laxatives	0.002	0.998	0.000
S42.40 Fracture of lower end of humerus (closed)	0.002	0.998	0.000
F23.3 Other acute predominantly delusional psychotic disorders	0.000	0.998	0.002
G91.9 Hydrocephalus, unspecified	0.002	0.998	0.000
T50.8 Diagnostic agents	0.002	0.998	0.000
K81 Cholecystitis	0.002	0.998	0.000
K46.1 Unspecified abdominal hernia with gangrene	0.002	0.998	0.000
M48.9 Spondylopathy, unspecified	0.002	0.998	0.000
M48.8 Other specified spondylopathies	0.002	0.998	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.002	0.998	0.000
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)	0.000	0.998	0.002
M48.06 Spinal stenosis (Lumbar region)	0.002	0.998	0.000
S32.70 Multiple fractures of lumbar spine and pelvis (closed)	0.000	0.998	0.002
M07.38 Other psoriatic arthropathies (Other)	0.000	0.998	0.002
M54.16 Radiculopathy (Lumbar region)	0.002	0.998	0.000
M18 Arthrosis of first carpometacarpal joint	0.002	0.998	0.000
M48.59 Collapsed vertebra, not elsewhere classified (Site unspecified)	0.002	0.998	0.000
M90.78 Fracture of bone in neoplastic disease (Other)	0.000	0.998	0.002
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
T37.5 Antiviral drugs	0.002	0.998	0.000
T37.4 Anthelminthics	0.002	0.998	0.000
T37.3 Other antiprotozoal drugs	0.002	0.998	0.000
T37.1 Antimycobacterial drugs	0.002	0.998	0.000
T37.0 Sulphonamides	0.002	0.998	0.000
T41.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
L97 Ulcer of lower limb, not elsewhere classified	0.002	0.998	0.000
M48.99 Spondylopathy, unspecified (Site unspecified)	0.002	0.998	0.000
L92.3 Foreign body granuloma of skin and subcutaneous tissue	0.000	0.998	0.002
T45.4 Iron and its compounds	0.001	0.998	0.000
T45.2 Vitamins, not elsewhere classified	0.001	0.998	0.000
M10 Gout	0.002	0.998	0.000
M07.30 Other psoriatic arthropathies (Multiple sites)	0.000	0.998	0.002
T40.5 Cocaine	0.002	0.998	0.000
G91.2 Normal-pressure hydrocephalus	0.001	0.998	0.000
M48.4 Fatigue fracture of vertebra	0.002	0.998	0.000
M48.3 Traumatic spondylopathy	0.002	0.998	0.000
M48.2 Kissing spine	0.002	0.998	0.000
M48.1 Ankylosing hyperostosis [Forestier]	0.002	0.998	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.002	0.998	0.000
T40.4 Other synthetic narcotics	0.002	0.998	0.000
M48.58 Collapsed vertebra, not elsewhere classified (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M48.57 Collapsed vertebra, not elsewhere classified (Lumbosacral region)	0.002	0.998	0.000
M48.53 Collapsed vertebra, not elsewhere classified (Cervicothoracic region)	0.002	0.998	0.000
M48.52 Collapsed vertebra, not elsewhere classified (Cervical region)	0.002	0.998	0.000
M48.51 Collapsed vertebra, not elsewhere classified (Occipito-atlanto-axial region)	0.002	0.998	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.001	0.998	0.000
T50.4 Drugs affecting uric acid metabolism	0.002	0.998	0.000
D11.0 Parotid gland	0.002	0.998	0.000
G91.1 Obstructive hydrocephalus	0.001	0.998	0.000
M18.3 Other posttraumatic arthrosis of first carpometacarpal joint	0.002	0.998	0.000
T36.9 Systemic antibiotic, unspecified	0.001	0.998	0.000
T36.7 Antifungal antibiotics, systemically used	0.001	0.998	0.000
T36.6 Rifamycins	0.001	0.998	0.000
T36.5 Aminoglycosides	0.001	0.998	0.000
T36.2 Chloramphenicol group	0.001	0.998	0.000
F23.9 Acute and transient psychotic disorder, unspecified	0.000	0.998	0.002
J39.2 Other diseases of pharynx	0.000	0.998	0.002
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
T44.0 Anticholinesterase agents	0.002	0.998	0.000
M54.17 Radiculopathy (Lumbosacral region)	0.002	0.998	0.000
S82.50 Fracture of medial malleolus (closed)	0.002	0.998	0.000
A31.9 Mycobacterial infection, unspecified	0.000	0.998	0.002
T36.4 Tetracyclines	0.001	0.998	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.002	0.998	0.000
T40.8 Lysergide [LSD]	0.002	0.998	0.000
T40.7 Cannabis (derivatives)	0.002	0.998	0.000
T40.0 Opium	0.002	0.998	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.998	0.000
M48.89 Other specified spondylopathies (Site unspecified)	0.002	0.998	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.001	0.998	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.002	0.998	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
C92.0 Acute myeloid leukaemia	0.000	0.998	0.002
T36.8 Other systemic antibiotics	0.001	0.998	0.000
T36.3 Macrolides	0.001	0.998	0.000
A31 Infection due to other mycobacteria	0.000	0.998	0.002
M48.50 Collapsed vertebra, not elsewhere classified (Multiple sites in spine)	0.001	0.998	0.000
M48.88 Other specified spondylopathies (Sacral and sacrococcygeal region)	0.001	0.998	0.000
K60.1 Chronic anal fissure	0.002	0.998	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.001	0.998	0.000
A30-A49 Other bacterial diseases	0.000	0.998	0.002
C32.0 Glottis	0.000	0.998	0.002
T40.3 Methadone	0.001	0.998	0.000
M48.87 Other specified spondylopathies (Lumbosacral region)	0.001	0.998	0.000
G99.0 Autonomic neuropathy in endocrine and metabolic diseases	0.001	0.998	0.000
T40.1 Heroin	0.001	0.998	0.000
M48.85 Other specified spondylopathies (Thoracolumbar region)	0.001	0.998	0.000
M48.84 Other specified spondylopathies (Thoracic region)	0.001	0.998	0.000
M48.83 Other specified spondylopathies (Cervicothoracic region)	0.001	0.998	0.000
M48.82 Other specified spondylopathies (Cervical region)	0.001	0.998	0.000
M48.81 Other specified spondylopathies (Occipito-atlanto-axial region)	0.001	0.998	0.000
M48.80 Other specified spondylopathies (Multiple sites in spine)	0.001	0.998	0.000
M48.98 Spondylopathy, unspecified (Sacral and sacrococcygeal region)	0.001	0.998	0.000
M48.97 Spondylopathy, unspecified (Lumbosacral region)	0.001	0.998	0.000
M48.95 Spondylopathy, unspecified (Thoracolumbar region)	0.001	0.998	0.000
M48.94 Spondylopathy, unspecified (Thoracic region)	0.001	0.998	0.000
M48.93 Spondylopathy, unspecified (Cervicothoracic region)	0.001	0.998	0.000
M48.91 Spondylopathy, unspecified (Occipito-atlanto-axial region)	0.001	0.998	0.000
M48.90 Spondylopathy, unspecified (Multiple sites in spine)	0.001	0.998	0.000
C53.9 Cervix uteri, unspecified	0.002	0.998	0.000
M18.9 Arthrosis of first carpometacarpal joint, unspecified	0.002	0.998	0.000
M18.5 Other secondary arthrosis of first carpometacarpal joint	0.001	0.998	0.000
M18.4 Other secondary arthrosis of first carpometacarpal joints, bilateral	0.001	0.998	0.000
M18.2 Posttraumatic arthrosis of first carpometacarpal joints, bilateral	0.001	0.998	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.001	0.998	0.000
A40 Streptococcal septicaemia	0.000	0.998	0.002
X49 Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances	0.002	0.998	0.000
M48.96 Spondylopathy, unspecified (Lumbar region)	0.001	0.998	0.000
A40.9 Streptococcal septicaemia, unspecified	0.000	0.998	0.001
T36.0 Penicillins	0.001	0.998	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.001	0.998	0.000
T45.5 Anticoagulants	0.001	0.998	0.001
M10.4 Other secondary gout	0.001	0.998	0.000
M10.2 Drug-induced gout	0.001	0.998	0.000
M10.1 Lead-induced gout	0.001	0.998	0.000
T40.2 Other opioids	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations